The Role of LILRB Family in Blood Cancers
Author Information
Author(s): Hodges Alan, Dubuque Rachel, Chen Shu-Hsia, Pan Ping-Ying
Primary Institution: Houston Methodist Research Institute
Hypothesis
How do LILRB proteins influence hematologic malignancies?
Conclusion
LILRB proteins are significant as diagnostic and prognostic biomarkers in blood cancers and may serve as therapeutic targets.
Supporting Evidence
- LILRB proteins are implicated in immune evasion in cancer.
- LILRB1 and LILRB4 are sensitive markers for acute myeloid leukemia.
- LILRB4 expression correlates with poor outcomes in multiple myeloma.
- LILRB proteins can influence the immune microenvironment in hematologic malignancies.
Takeaway
LILRB proteins help doctors understand and treat blood cancers better by acting as markers for diagnosis and potential treatment targets.
Methodology
This review synthesizes existing literature on LILRB proteins in hematologic malignancies.
Potential Biases
Potential bias in the interpretation of LILRB roles due to the focus on specific malignancies.
Limitations
The review primarily focuses on AML, with less data on other hematologic malignancies.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website